• WuXi Biologics, Bioasis in Strategic Dev./Mfg. Alliance contractpharma
    May 22, 2018
    WuXi Biologics and Bioasis Technologies, Inc. have entered an initial strategic collaboration for the development and manufacture of xB3-001, Bioasis' lead biologic candidate to treat brain cancer.
PharmaSources Customer Service